Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 500124 | NSE Symbol : DRREDDY | ISIN : INE089A01031 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(03-Jun-25 16:28) Dr Reddys Laboratories allots 57,840 equity shares under ESOS
(26-May-25 09:33) Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA
(19-May-25 08:32) DRL’s USA facility gets 2 observations from USFDA
(17-May-25 11:32) USFDA completes GMP inspection of Dr Reddy's Middleburgh facility in New York
(12-May-25 14:50) Dr Reddys Lab jumps after Q4 PAT rises 22% YoY
(10-May-25 10:52) Dr Reddys Lab Q4 PAT rises 22% YoY
(10-May-25 10:17) Dr Reddys Laboratories AGM scheduled
(09-May-25 19:13) Dr Reddys Laboratories fixes record date for final dividend
(09-May-25 17:18) Dr Reddy's Laboratories consolidated net profit rises 21.64% in the March 2025 quarter
(09-May-25 17:01) Board of Dr Reddys Laboratories recommends Final Dividend

1 2 3 4 5 6 7 8 9 10

Dr Reddys Laboratories Ltd